| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc. (RXRX) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 17 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.65M | $21.15M | - | |
| Dir | 4.52M | $14.38M | - | |
| CEO | 2.26M | $7.19M | - | |
| Dir | 1.24M | $3.95M | - | |
| Other | 1.11M | $3.53M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 6, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell | 100,000 | $8.71 | $871,000.00 | -6.4% | -32.3% | -39.1% | |
| May 30, 2024 | Marriott Tina73 | President And COO | Sale+OE | 3,000 | $8.78 | $26,325.00 | -0.6% | -16.9% | -52.9% | |
| May 28, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $9.17 | $104,942.66 | -0.2% | -12.2% | -51.1% | |
| May 14, 2024 | Borgeson Blake69 | Director | Sell | 20,054 | $10.12 | $202,934.45 | -0.3% | -40.0% | -57.1% | |
| May 2, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell | 100,000 | $8.10 | $810,000.00 | -3.8% | -6.7% | -35.2% | |
| Apr 30, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $7.95 | $90,963.59 | -0.2% | +4.7% | -28.5% | |
| Apr 25, 2024 | Marriott Tina73 | President And COO | Sale+OE | 3,000 | $7.67 | $23,020.50 | -0.5% | -0.4% | -26.9% | |
| Apr 17, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE | 48,124 | $7.63 | $367,006.79 | -1.9% | +15.1% | -26.4% | |
| Apr 16, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $7.66 | $87,725.23 | -0.2% | +8.3% | -29.7% | |
| Apr 4, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell | 130,000 | $8.93 | $1,160,900.00 | -6.4% | -15.8% | -51.4% |